Latest Proof Of Concept News

Page 10 of 23
Elsight Limited has reported a staggering 12-fold revenue increase in Q1 2026 to US$11.6 million, driven by strong U.S. defence contracts and early commercial traction. The company also soft-launched a GNSS-denied positioning product, marking a strategic shift toward a broader uncrewed systems platform.
Sophie Babbage
Sophie Babbage
22 Apr 2026
SRJ Technologies has locked in a three-year, US$4.4 million deal to deploy its robotic leak detection and emissions inspection services for a major UAE state-owned oil and gas operator, following a successful proof-of-concept trial.
Maxwell Dee
Maxwell Dee
20 Apr 2026
PYC Therapeutics has secured Safety Review Committee approval to escalate dosing of its investigational drug PYC-001 for Autosomal Dominant Optic Atrophy from single to multiple doses, marking a key step in its clinical development.
Ada Torres
Ada Torres
15 Apr 2026
Prairie Lithium is poised to begin commercial lithium production in Q4 2026 as its Direct Lithium Extraction facility nears completion, backed by a binding offtake agreement covering 100% of Phase 1 output and a strategic AU$10 million equipment contribution from Hydro Lithium.
Maxwell Dee
Maxwell Dee
13 Apr 2026
Marquee Resources has entered a 24-month patent license and option agreement with UT-Battelle LLC, granting access to advanced rare earth element separation technologies from Oak Ridge National Laboratory. This positions Marquee to explore downstream processing opportunities for its Redlings REE Project in Western Australia.
Maxwell Dee
Maxwell Dee
9 Apr 2026
Radiopharm Theranostics has received a positive recommendation to escalate the dose of its 177Lu-RAD202 radiotherapeutic in a Phase 1 trial targeting HER2-positive advanced solid tumors, maintaining its timeline to complete dose escalation by year-end 2026.
Ada Torres
Ada Torres
8 Apr 2026
Archer Materials has progressed its Biochip program by completing the alpha prototype and Stage 1 project with IMEC, now advancing to develop a beta prototype suitable for external use and clinical validation.
Sophie Babbage
Sophie Babbage
7 Apr 2026
InFocus Group Holdings has completed Codexa, a proprietary sweepstakes casino platform targeting the booming US market, with plans for licensing and potential sale.
Sophie Babbage
Sophie Babbage
27 Mar 2026
Norwood Systems Limited reported a significant revenue increase for the half-year ended December 2025, alongside a widening net loss and strategic progress with Tier-1 telecom customers. The company secured additional funding and advanced its AI-driven voice platforms in collaboration with global hyperscalers.
Sophie Babbage
Sophie Babbage
27 Feb 2026
HyTerra Limited has partnered with Prometheus Hydrogen to demonstrate an integrated geologic hydrogen production and delivery system in the US, aiming to complete by December 2026. This collaboration could pave the way for commercial-scale hydrogen supply to government and defense sectors.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Patrys Limited reported a near doubling of its half-year loss to $3.02 million, driven by restructuring and a strategic pivot including the acquisition of Reliis Pty Ltd. The company is advancing a dual-platform biotech strategy combining a clinical-stage CNS asset with its proprietary antibody platform.
Ada Torres
Ada Torres
26 Feb 2026
Beonic Limited reported a 5.5% revenue increase to $11.2 million and reduced its net loss to $1.44 million for the half-year ending December 2025. The company also repaid a $4.65 million loan and secured a major $7.3 million contract to deploy passenger flow management solutions across seven Moroccan airports.
Sophie Babbage
Sophie Babbage
26 Feb 2026

Browse the archive

Full archive